Ad5F35-LMP1 LMP2-Transduced Autologous Dendritic Cells
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Biological Agent ->
Autologous Lymphocytes ->
Autologous Dendritic Cells -> Ad5F35-LMP1 LMP2-Transduced Autologous Dendritic Cells
Ad5F35-LMP1 LMP2-Transduced Autologous Dendritic Cells Definition
Autologous dendritic cells (DCs) transduced with the replication-deficient adenoviral vector Ad5F53 encoding the Epstein-Barr virus (EBV) transmembrane latent membrane proteins 1 and 2 (LMP1/LMP2) with potential immunostimulatory activity. Vaccination with Ad5F35-LMP1/LMP2-transduced autologous dendritic cells may stimulate a specific cytotoxic T-lymphocyte (CTL) response against LMP1- and LMP2-expressing tumor positive cells, resulting in tumor cell lysis and inhibition of tumor cell proliferation. LMP1 and LMP2 are expressed in various malignancies including nasopharyngeal cancer and EBV-positive Hodgkins disease.
Ad5F35-LMP1 LMP2-Transduced Autologous Dendritic Cells Synonyms
Ad5F35-LMP1/LMP2-Transduced Autologous Dendritic Cells
Terms in Ad5F35-LMP1 LMP2-Transduced Autologous Dendritic Cells category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.